Valuation
- Market cap
- —
- Revenue TTM
- $0
- Net income TTM
- $0
- P/E (trailing)
- —
- P/E (forward)
- —
- Profit margin
- 0.00%
- Debt to equity
- —
Trading
- Volume
- 8,600
- Avg volume
- 19,912
- Day's range
- $0.00 – $0.01
- Shares out
- —
- Stochastic %K
- 8%
- Beta
- —
- Analysts
- —
- Price target
- —
Company profile
Ludwig Enterprises, Inc. operates as a genomic technology focused on developing testing approaches for inflammation-related chronic diseases, including cancers in the United States. The company integrates mRNA inflammatory biomarkers, proprietary machine-learning algorithms, and at-home cheek swab collection kits for cancer identification. It offers mRNA-based screening to provide early insights of potential health r...
Show more
Ludwig Enterprises, Inc. operates as a genomic technology focused on developing testing approaches for inflammation-related chronic diseases, including cancers in the United States. The company integrates mRNA inflammatory biomarkers, proprietary machine-learning algorithms, and at-home cheek swab collection kits for cancer identification. It offers mRNA-based screening to provide early insights of potential health risks. The company develops Revealia Breast test, a non-invasive cheek swab screening kit designed to identify and analyze molecular signatures in mRNA expression associated with inflammation-related biological processes associated with the presence of breast cancer. Ludwig Enterprises, Inc. was founded in 1988 and is based in Miami, Florida.
- Industry
- Medical Devices
- Sector
- Healthcare
- Phone
- 786 363 0166
- Website
- https://ludwigent.com
- Address
- 8950 SW 74th Ct, Ste 2201-A149, Miami, United States
Latest news
No headlines yet.
